Abstract
Purpose of Review
Surgical repair of pelvic organ prolapse (POP) is common and a significant number of women will experience POP recurrence. This paper provides a summary of management options for recurrent POP.
Recent Findings
Vaginal and abdominal approaches to recurrent POP utilizing native tissues, previously placed mesh, or a new mesh implant are all reasonable options for repair. Choice of surgical approach should be individualized to the patient.
Summary
Without evidence from randomized controlled studies to help clinicians delineate the appropriate repair for each patient, there is still no perfect answer as to the best surgical treatment for recurrent POP. Similar to primary repairs, vaginal and abdominal approaches to recurrent POP utilizing either native tissues or polypropylene mesh (new or previously placed) are all reasonable options for repair. In the hands of an experienced pelvic reconstructive surgeon, complication rates from mesh implantation are limited while potential benefits of additional strength and durability are offered. Debate continues over the appropriate use of polypropylene mesh for pelvic reconstruction in women with prolapse; in the setting of recurrent bothersome prolapse mesh may offer a durable option.
Similar content being viewed by others
Abbreviations
- ICS:
-
International Continence Society
- IUGA:
-
International Urogynecological Association
- POP:
-
pelvic organ prolapse
- POP-Q:
-
Pelvic Organ Prolapse Quantification System
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Haylen BT, Maher CF, Barber MD, Camargo S, Dandolu V, Digesu A, et al. An International Urogynecological Association (IUGA) / International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP). Neurourol Urodyn. 2016;35(2):137–68.
Winters JC, Smith AL, Krlin RM. Vaginal and abdominal reconstructive surgery for pelvic organ prolapse. In: Wein AJ, Kavoussi LR, Partin AW, Peters CA, editors. Campbell-Walsh urology. 11th ed. Philadelphia: Elsevier; 2016.
Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997;89(4):501–6.
Denman MA, Gregory WT, Boyles SH, Smith V, Edwards SR, Clark AL. Reoperation 10 years after surgically managed pelvic organ prolapse and urinary incontinence. Am J Obstet Gynecol. 2008;198(5):555 e1–5.
•• Ismail S, Duckett J, Rizk D, Sorinola O, Kammerer-Doak D, Contreras-Ortiz O, et al. Recurrent pelvic organ prolapse: International Urogynecological Association Research and Development Committee opinion. Int Urogynecol J. 2016;27(11):1619–32. Recently published international committee opinion paper that sumarizes available evidence on recurrent pelvic organ prolapse and provides guidance on management.
Barber MD, Brubaker L, Nygaard I, Wheeler TL 2nd, Schaffer J, Chen Z, et al. Defining success after surgery for pelvic organ prolapse. Obstet Gynecol. 2009;114(3):600–9.
Swift S, Woodman P, O'Boyle A, Kahn M, Valley M, Bland D, et al. Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects. Am J Obstet Gynecol. 2005;192(3):795–806.
Toozs-Hobson P, Freeman R, Barber M, Maher C, Haylen B, Athanasiou S, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for reporting outcomes of surgical procedures for pelvic organ prolapse. Neurourol Urodyn. 2012;31(4):415–21.
Diez-Itza I, Aizpitarte I, Becerro A. Risk factors for the recurrence of pelvic organ prolapse after vaginal surgery: a review at 5 years after surgery. Int Urogynecol J Pelvic Floor Dysfunct. 2007;18(11):1317–24.
Salvatore S, Athanasiou S, Digesu GA, Soligo M, Sotiropoulou M, Serati M, et al. Identification of risk factors for genital prolapse recurrence. Neurourol Urodyn. 2009;28(4):301–4.
Whiteside JL, Weber AM, Meyn LA, Walters MD. Risk factors for prolapse recurrence after vaginal repair. Am J Obstet Gynecol. 2004;191(5):1533–8.
Clark AL, Gregory T, Smith VJ, Edwards R. Epidemiologic evaluation of reoperation for surgically treated pelvic organ prolapse and urinary incontinence. Am J Obstet Gynecol. 2003;189(5):1261–7.
Fialkow MF, Newton KM, Lentz GM, Weiss NS. Lifetime risk of surgical management for pelvic organ prolapse or urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(3):437–40.
Dallenbach P, Jungo Nancoz C, Eperon I, Dubuisson JB, Boulvain M. Incidence and risk factors for reoperation of surgically treated pelvic organ prolapse. Int Urogynecol J. 2012;23(1):35–41.
Oversand SH, Staff AC, Spydslaug AE, Svenningsen R, Borstad E. Long-term follow-up after native tissue repair for pelvic organ prolapse. Int Urogynecol J. 2014;25(1):81–9.
Moen M, Noone M, Vassallo B. Anterior colporrhaphy: why surgeon performance is paramount. Int Urogynecol J. 2014;25(7):857–62.
Altman D, Vayrynen T, Engh ME, Axelsen S, Falconer C. Nordic transvaginal mesh G. Anterior colporrhaphy versus transvaginal mesh for pelvic-organ prolapse. N Engl J Med. 2011;364(19):1826–36.
Colombo M, Vitobello D, Proietti F, Milani R. Randomised comparison of Burch colposuspension versus anterior colporrhaphy in women with stress urinary incontinence and anterior vaginal wall prolapse. BJOG. 2000;107(4):544–51.
Eilber KS, Alperin M, Khan A, Wu N, Pashos CL, Clemens JQ, et al. Outcomes of vaginal prolapse surgery among female Medicare beneficiaries: the role of apical support. Obstet Gynecol. 2013;122(5):981–7.
Lavelle RS, Christie AL, Alhalabi F, Zimmern PE. Risk of prolapse recurrence after native tissue anterior vaginal suspension procedure with intermediate to long-term followup. J Urol. 2016;195(4 Pt 1):1014–20.
• Maher C, Feiner B, Baessler K, Christmann-Schmid C, Haya N, Brown J. Surgery for women with anterior compartment prolapse. Cochrane Database Syst Rev. 2016;11:CD004014. A cochrane database systematic review that summarizes safety and efficacy of surgical interventions for the management of anterior compartment prolapse.
Mowat A, Maher D, Baessler K, Christmann-Schmid C, Haya N, Maher C. Surgery for women with posterior compartment prolapse. Cochrane Database Syst Rev. 2018;3:CD012975.
• Maher C, Feiner B, Baessler K, Christmann-Schmid C, Haya N, Brown J. Surgery for women with apical vaginal prolapse. Cochrane Database Syst Rev. 2016;10:CD012376. A cochrane database systematic review that summarizes safety and efficacy of surgical interventions for the management of apical vaginal prolapse.
Jonsson Funk M, Visco AG, Weidner AC, Pate V, Wu JM. Long-term outcomes of vaginal mesh versus native tissue repair for anterior vaginal wall prolapse. Int Urogynecol J. 2013;24(8):1279–85.
Urogynecologic Surgical Mesh: Update on the Safety and Effectiveness of Vaginal Placement for Pelvic Organ Prolapse: Center for Devices and Radiological Health, Food and Drug Administration; July 2011 [Available from: http://proxy.library.upenn.edu:2157/downloads/medicaldevices/safety/alertsandnotices/UCM262760.pdf.
Tate SB, Blackwell L, Lorenz DJ, Steptoe MM, Culligan PJ. Randomized trial of fascia lata and polypropylene mesh for abdominal sacrocolpopexy: 5-year follow-up. Int Urogynecol J. 2011;22(2):137–43.
• Maher C, Feiner B, Baessler K, Christmann-Schmid C, Haya N, Marjoribanks J. Transvaginal mesh or grafts compared with native tissue repair for vaginal prolapse. Cochrane Database Syst Rev. 2016;2:CD012079. A cochrane database systematic review that summarizes safety and efficacy of transvaginal mesh or grafts compared with native tissue repair for vaginal prolapse.
Toh VV, Bogne V, Bako A. Management of recurrent vault prolapse. Int Urogynecol J. 2012;23(1):29–34.
Jelovsek JE, Maher C, Barber MD. Pelvic organ prolapse. Lancet. 2007;369(9566):1027–38.
Reid RI. Repair of recurrent prolapse. Best Pract Res Clin Obstet Gynaecol. 2011;25(2):175–96.
Norinho de Oliveira P, Bourdel N, Rabischong B, Canis M, Botchorishvili R. What to do with recurrent prolapse after vaginal mesh failure? J Minim Invasive Gynecol. 2016;23(2):161–2.
Schmid C, O'Rourke P, Maher C. Laparoscopic sacrocolpopexy for recurrent pelvic organ prolapse after failed transvaginal polypropylene mesh surgery. Int Urogynecol J. 2013;24(5):763–7.
Nygaard I, Brubaker L, Zyczynski HM, Cundiff G, Richter H, Gantz M, et al. Long-term outcomes following abdominal sacrocolpopexy for pelvic organ prolapse. JAMA. 2013;309(19):2016–24.
Nygaard IE, McCreery R, Brubaker L, Connolly A, Cundiff G, Weber AM, et al. Abdominal sacrocolpopexy: a comprehensive review. Obstet Gynecol. 2004;104(4):805–23.
Linder BJ, Chow GK, Elliott DS. Long-term quality of life outcomes and retreatment rates after robotic sacrocolpopexy. Int J Urol. 2015;22(12):1155–8.
Bracken JN, Tran DH, Kuehl TJ, Larsen W, Yandell PM, Shull BL. A novel transvaginal approach to correct recurrent apical prolapse after failed sacral colpopexy: case series. Int Urogynecol J. 2012;23(10):1429–33.
Linder BJ, Gebhart JB, Occhino JA. Total colpocleisis: technical considerations. Int Urogynecol J. 2016;27(11):1767–9.
DeLancey JO, Morley GW. Total colpocleisis for vaginal eversion. Am J Obstet Gynecol. 1997;176(6):1228–32. discussion 32-5
FitzGerald MP, Richter HE, Siddique S, Thompson P, Zyczynski H. Ann Weber for the pelvic floor disorders N. Colpocleisis: a review. Int Urogynecol J Pelvic Floor Dysfunct. 2006;17(3):261–71.
Hoskey KA, Shippey SH, Handa VL. Surgical repair of recurrent prolapse after LeFort colpocleisis. Int Urogynecol J. 2012;23(3):371–3.
Curtiss N, Duckett J. A long-term cohort study of surgery for recurrent prolapse comparing mesh augmented anterior repairs to anterior colporrhaphy. Gynecol Surg. 2018;15(1):1.
Dallas KB, Rogo-Gupta L, Elliott CS. What impacts the all cause risk of reoperation after pelvic organ prolapse repair? A comparison of mesh and native tissue approaches in 110,329 women. J Urol. 2018.
Nussler EK, Greisen S, Kesmodel US, Lofgren M, Bek KM, Glavind-Kristensen M. Operation for recurrent cystocele with anterior colporrhaphy or non-absorbable mesh: patient reported outcomes. Int Urogynecol J. 2013;24(11):1925–31.
Milani AL, Damoiseaux A, IntHout J, Kluivers KB, Withagen MIJ. Long-term outcome of vaginal mesh or native tissue in recurrent prolapse: a randomized controlled trial. Int Urogynecol J. 2018;29(6):847–58.
Wu PY, Chang CH, Shen MR, Chou CY, Yang YC, Huang YF. Seeking new surgical predictors of mesh exposure after transvaginal mesh repair. Int Urogynecol J. 2016;27(10):1547–55.
Author information
Authors and Affiliations
Ethics declarations
Conflict of Interest
No disclosures for any contributing author.
Additional information
This article is part of the Topical Collection on Stress Incontinence and Prolapse
Rights and permissions
About this article
Cite this article
Hartigan, S.M., Smith, A.L. So the First Pelvic Organ Prolapse Repair Failed…Now What?. Curr Bladder Dysfunct Rep 13, 238–243 (2018). https://doi.org/10.1007/s11884-018-0484-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11884-018-0484-1